ÃÊ·ÏÁ¢¼ö: 4¿ù 1ÀÏ~5¿ù 24ÀÏ
»çÀüµî·Ï: 5¿ù 1ÀÏ~6¿ù 14ÀÏ

6¿ù 27ÀÏ ±Ý¿äÀÏ
½Ã°£ ³»¿ë
08:00-08:45 Morning Seminar 2: Case discussion of partial epilepsy ÁÂÀå : ¹Ú¼ºÆÄ
08:00-08:20 Pediatric case(15ºÐ) ÀÌÁöÈÆ (¼º´ëÀÇ´ë ¼Ò¾Æ°ú)
08:20-08:40 Adult case(15ºÐ) È«¼®È£ (¼­¿ï¾Æ»êº´¿ø ½Å°æ¿Ü°ú)
08:40-08:45 Difficult case(15ºÐ) ¼­´ë¿ø (¼º´ëÀÇ´ë ½Å°æ°ú)
08:50-10:30
Plenary Session 2: Prognosis of epilepsy ÁÂÀå : ±èÁÖÇÑ, ȲűÔ
Long-term prognosis in children with epilepsy(25ºÐ) ¿¬¼¼ÀÇ´ë ÀÌÁؼö
Nnatural history in adult with epilepsy(25ºÐ) ÀÎÁ¦ÀÇ´ë ±è¼ºÀº
Surgical outcome & prognosis of epilepsy(25ºÐ) °è¸íÀÇ´ë ¼ÕÀºÀÍ
SUDEP(25ºÐ) ºÀ»ýº´¿ø ³ë¼ø±â
10:30-10:40 Coffee Break
10:40-11:50
Platform Session Platform Session
12:00-13:50 Lunch & UCB Satellite Symposium Exploring Optimal Treatment Options in Epilepsy
ÁÂÀå ±èÀç¹®

A Key Determinant of Success in Epilepsy Treatment (30ºÐ) Prof. David Y Ko
Synaptic Modulation by Levetiracetam: Experimental Evidences (30ºÐ) ¼­¿ïÀÇ´ë ÁÖ °Ç
Levetiracetam : Novel Options for Pediatric Epilepsy Patients (30ºÐ) °í·ÁÀÇ´ë Àº¹é¸°
14:00-16:55
JES-KES Joint Symposium
ÁÂÀå Yi SD (ÀÌ»óµµ, °è¸íÀÇ´ë ½Å°æ°ú), Sunao Kaneko (È÷·Î»çŰÀÇ´ë ½Å°æÁ¤½Å°ú)
»çȸ HK Song (¼ÛÈ«±â, ÇѸ²ÀÇ´ë ½Å°æ°ú)
14:05 -14:25Plenary Session
Refractory epilepsy: overview
BI Lee (À̺´ÀÎ, ¿¬¼¼ÀÇ´ë ½Å°æ°ú)
14:25-14:45 Pathomechanism and neural substrate of refractory epilepsy Tatsuya Tanaka (¾Æ»çÈ÷°¡¿ÍÀÇ´ë ½Å°æ¿Ü°ú)
14:45-15:05Pharmacogenetics in Epilepsy
Korean data (10min)
Japanese data (10min)

E Kim (±è¼ºÀº, ÀÎÁ¦ÀÇ´ë ½Å°æ°ú)
Sunao Kaneko (È÷·Î»çŰÀÇ´ë ½Å°æÁ¤½Å°ú)
Coffee Break (10 ºÐ)
Free paper presentation
    - Moderator: SC Hong (È«½Âö, ¼º±Õ°üÀÇ´ë ½Å°æ¿Ü°ú)(8min presentation and 5min discussion)
SB Hong(È«½ÂºÀ, ¼º±Õ°üÀÇ´ë ½Å°æ°ú)
Masami Fujii (¾Æ¸¶±¸Ä¡ÀÇ´ë ½Å°æ¿Ü°ú)
JM Kim (±èÀç¹® Ãæ³²ÀÇ´ë ½Å°æ°ú)
Nobukazu Nakasato(µµÈ£ÄíÀÇ´ë ½Å°æ¿Ü°ú)
CK Chung (Á¤Ãµ±â, ¼­¿ïÀÇ´ë ½Å°æ¿Ü°ú)
Riki Matsumoto (±³ÅäÀÇÇдëÇпø ½Å°æ°ú)
HD Kim (±èÈﵿ, ¿¬¼¼ÀÇ´ë ¼Ò¾Æ°ú)
Yoshiya Marushima (Åä±³Á¤½Å¼¾ÅÍ ¼ö¼®¿¬±¸¿ø)
  1. È«½ÂºÀ: Comprehensive Epilepsy Program in Korea
  2. ±èÀç¹®: Clinical Experience of New Generation Antiepilepstic Drugs over 10 years in Korea
  3. Á¤Ãµ±â The Clinical Results of Six Cases of Insular Tumor Resection.
  4. ±èÈﵿ: Outcome of Resective Surgery in Lennox-Gastaut Syndrome
17:00-17:30 Special Lecture: Treatment Goal of AED Therapy(30ºÐ) - ¿¬¼¼ÀÇ´ë À̺´ÀÎ
17:40-19:10
Novartis satellite symposium:
Adverse Effects of AEDs
ÁÂÀå: È«½ÂºÀ, ±èµ¿¿í
Consideration in the choice of AED (15ºÐ)
¼º±Õ°üÀÇ´ë È«½ÂºÀ
What is adverse event? (15ºÐ)
¿¬¼¼ÀÇ´ë ±è¿øÁÖ
Side effect of AED: childhood issues (15ºÐ)
¼­¿ïÀÇ´ë ±è±âÁß
Side effect of AED: elderly issues (15ºÐ)
Àü³²ÀÇ´ë ±è¸í±Ô
Side effect of AED: women (15ºÐ)
ÀÌÈ­ÀÇ´ë ÀÌÇâ¿î
Pediatric Epilepsy:
Energy metabolism disorder and Epilepsy
ÁÂÀå : ¿ì¿µÁ¾, ¹®Çѱ¸
Epileptogenesis and Mitochondrial dysfunction(20ºÐ)
¼­¿ïÀÇ´ë äÁ¾Èñ
MRC Defect Newly Postulated Etiology in Various Epileptic Condition(20ºÐ)
¿¬¼¼ÀÇ´ë ÀÌ¿µ¸ñ
Encephalopathy due to glucose transporter type 1 deficiency syndrome(20ºÐ)
ÇѸ²ÀÇ´ë ±è¼º±¸
Neuroradiologic Findings in Children with Mitochondrial Disorder:
Correlation with Mitochondrial Respiratory Chain Defects(20ºÐ)
¿¬¼¼ÀÇ´ë ±èÁø¾Æ
Questions and comments (10ºÐ)
   19:00- Dinner & ÃÑȸ